Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Atzeni

Showing results (91-100 of 109) with videos related to

Pageof 11
Sort By:
Clinical and Experimental Rheumatology|February 10, 2006
Skin manifestations in vasculitis and erythema nodosumF Atzeni, M Carrabba, J C Davin, et al.
The American Journal of Gastroenterology|July 1, 1998
Thyroid and celiac disease: clinical, serological, and echographic studyF Velluzzi, A Caradonna, M F Boy, et al.
Clinical and Experimental Rheumatology|February 26, 2014
New parameters for identifying subclinical atherosclerosis in patients with primary Sjögren's syndrome: a pilot studyF Atzeni, P Sarzi-Puttini, M C Signorello, et al.
Clinical and Experimental Rheumatology|July 1, 2008
HCV infection: pathogenesis, clinical manifestations and therapyA Antonelli, C Ferri, M Galeazzi, et al.
Rheumatology (Oxford, England)|September 15, 2007
Lack of association of the -463 G/A myeloperoxidase promoter polymorphism with Behcet's disease in Italian patientsF Atzeni, L Boiardi, B Casali, et al.
Clinical and Experimental Rheumatology|October 3, 2009
Protein Z G79A and A-13G gene polymorphisms in Italian patients with Behçet's diseaseA Ghinoi, L Boiardi, F Atzeni, et al.
Clinical and Experimental Rheumatology|October 3, 2009
Toll-like receptor 4 (TLR4) gene polymorphisms in Italian patients with Behçet's diseaseL Boiardi, F Atzeni, B Casali, et al.
Autoimmunity Reviews|August 4, 2010
From endothelial dysfunction to atherosclerosisS Sitia, L Tomasoni, F Atzeni, et al.
Clinical Rheumatology|October 6, 2017
Real-world experience of tocilizumab in rheumatoid arthritis: sub-analysis of data from the Italian biologics' register GISEAF Iannone, G Ferraccioli, L Sinigaglia, et al.
Reumatismo|January 22, 2011
Study on the possible role of the -174G>C IL-6 promoter polymorphism in predicting response to rituximab in rheumatoid arthritisM Fabris, L Quartuccio, S Lombardi, et al.
Pageof 11

Showing results (91-100 of 109) with videos related to

Sort By:
Pageof 11
Clinical and Experimental Rheumatology|February 10, 2006
Skin manifestations in vasculitis and erythema nodosumF Atzeni, M Carrabba, J C Davin, et al.
The American Journal of Gastroenterology|July 1, 1998
Thyroid and celiac disease: clinical, serological, and echographic studyF Velluzzi, A Caradonna, M F Boy, et al.
Clinical and Experimental Rheumatology|February 26, 2014
New parameters for identifying subclinical atherosclerosis in patients with primary Sjögren's syndrome: a pilot studyF Atzeni, P Sarzi-Puttini, M C Signorello, et al.
Clinical and Experimental Rheumatology|July 1, 2008
HCV infection: pathogenesis, clinical manifestations and therapyA Antonelli, C Ferri, M Galeazzi, et al.
Rheumatology (Oxford, England)|September 15, 2007
Lack of association of the -463 G/A myeloperoxidase promoter polymorphism with Behcet's disease in Italian patientsF Atzeni, L Boiardi, B Casali, et al.
Clinical and Experimental Rheumatology|October 3, 2009
Protein Z G79A and A-13G gene polymorphisms in Italian patients with Behçet's diseaseA Ghinoi, L Boiardi, F Atzeni, et al.
Clinical and Experimental Rheumatology|October 3, 2009
Toll-like receptor 4 (TLR4) gene polymorphisms in Italian patients with Behçet's diseaseL Boiardi, F Atzeni, B Casali, et al.
Autoimmunity Reviews|August 4, 2010
From endothelial dysfunction to atherosclerosisS Sitia, L Tomasoni, F Atzeni, et al.
Clinical Rheumatology|October 6, 2017
Real-world experience of tocilizumab in rheumatoid arthritis: sub-analysis of data from the Italian biologics' register GISEAF Iannone, G Ferraccioli, L Sinigaglia, et al.
Reumatismo|January 22, 2011
Study on the possible role of the -174G>C IL-6 promoter polymorphism in predicting response to rituximab in rheumatoid arthritisM Fabris, L Quartuccio, S Lombardi, et al.
Pageof 11